Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nilapanib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461597A reveals a cost-effective photoredox/Ni dual catalytic route for nilapanib intermediates, offering significant supply chain stability and reduced manufacturing costs.
Patent CN115611860A discloses a safe, high-yield Niraparib synthesis avoiding sodium azide. Ideal for cost reduction in API manufacturing and supply chain stability.